Dose‐dependent efficacy of the glucose‐dependent insulinotropic polypeptide ( GIP) receptor antagonist GIP (3‐30) NH 2 on GIP actions in humans
Year: 2020
Type: article
Study design: Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.14186
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G7548833942
OpenAlex ID: W3082996808
